Stephanie Byrum
Concepts (515)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 31 | 2024 | 329 | 6.170 |
Why?
| Proteome | 19 | 2024 | 173 | 4.170 |
Why?
| Histones | 16 | 2023 | 312 | 2.620 |
Why?
| Protein Processing, Post-Translational | 10 | 2024 | 171 | 2.470 |
Why?
| Software | 3 | 2024 | 273 | 2.190 |
Why?
| Mass Spectrometry | 18 | 2024 | 306 | 2.160 |
Why?
| Chromatin | 12 | 2023 | 151 | 1.930 |
Why?
| Protein Interaction Mapping | 3 | 2020 | 40 | 1.280 |
Why?
| Saccharomyces cerevisiae Proteins | 9 | 2019 | 152 | 1.240 |
Why?
| Saccharomyces cerevisiae | 9 | 2019 | 190 | 1.110 |
Why?
| Mice | 43 | 2024 | 5739 | 1.090 |
Why?
| Animals | 56 | 2024 | 13187 | 1.050 |
Why?
| Bacterial Proteins | 5 | 2020 | 376 | 1.020 |
Why?
| Computational Biology | 3 | 2024 | 214 | 0.980 |
Why?
| Chromosomal Proteins, Non-Histone | 5 | 2021 | 40 | 0.940 |
Why?
| Transcriptome | 5 | 2022 | 315 | 0.900 |
Why?
| Staphylococcus aureus | 4 | 2020 | 326 | 0.890 |
Why?
| Polycomb-Group Proteins | 2 | 2021 | 9 | 0.880 |
Why?
| Trichloroethylene | 2 | 2024 | 66 | 0.860 |
Why?
| Melanoma | 6 | 2024 | 285 | 0.860 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2023 | 62 | 0.860 |
Why?
| DNA Methylation | 5 | 2024 | 548 | 0.850 |
Why?
| Peptide Hydrolases | 2 | 2020 | 62 | 0.800 |
Why?
| Signal Transduction | 7 | 2022 | 1618 | 0.790 |
Why?
| Genomics | 2 | 2021 | 286 | 0.760 |
Why?
| Endothelial Cells | 7 | 2024 | 269 | 0.710 |
Why?
| Phosphoproteins | 1 | 2020 | 107 | 0.680 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2024 | 164 | 0.660 |
Why?
| Binding Sites | 1 | 2019 | 374 | 0.630 |
Why?
| Environmental Exposure | 1 | 2019 | 199 | 0.600 |
Why?
| Protein Binding | 8 | 2021 | 660 | 0.570 |
Why?
| Blood Proteins | 1 | 2017 | 82 | 0.560 |
Why?
| Humans | 53 | 2024 | 49974 | 0.560 |
Why?
| Whole-Body Irradiation | 1 | 2017 | 131 | 0.550 |
Why?
| Mitochondria | 4 | 2024 | 402 | 0.530 |
Why?
| Chromatography, Affinity | 2 | 2012 | 38 | 0.520 |
Why?
| Space Flight | 3 | 2020 | 34 | 0.510 |
Why?
| Chemical Fractionation | 1 | 2015 | 17 | 0.500 |
Why?
| Epigenesis, Genetic | 8 | 2024 | 374 | 0.480 |
Why?
| Bone Neoplasms | 3 | 2013 | 179 | 0.460 |
Why?
| MicroRNAs | 3 | 2023 | 353 | 0.460 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 142 | 0.430 |
Why?
| Gene Expression Regulation, Neoplastic | 7 | 2021 | 828 | 0.420 |
Why?
| Chromatin Immunoprecipitation | 1 | 2012 | 49 | 0.420 |
Why?
| Osteoclasts | 4 | 2024 | 425 | 0.410 |
Why?
| Nevus, Pigmented | 2 | 2012 | 35 | 0.410 |
Why?
| Cell Line, Tumor | 9 | 2024 | 1403 | 0.400 |
Why?
| Diet, High-Fat | 2 | 2024 | 222 | 0.390 |
Why?
| Mice, Inbred C57BL | 12 | 2024 | 1816 | 0.390 |
Why?
| Skin Neoplasms | 2 | 2020 | 488 | 0.390 |
Why?
| Methionine | 2 | 2024 | 135 | 0.390 |
Why?
| Cluster Analysis | 3 | 2023 | 235 | 0.390 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2021 | 33 | 0.390 |
Why?
| Transcription Factors | 6 | 2021 | 561 | 0.380 |
Why?
| Lysine | 3 | 2023 | 89 | 0.380 |
Why?
| Virulence | 4 | 2020 | 173 | 0.370 |
Why?
| DNA-Binding Proteins | 4 | 2021 | 427 | 0.370 |
Why?
| Bone Resorption | 2 | 2024 | 304 | 0.360 |
Why?
| Gene Silencing | 3 | 2023 | 119 | 0.360 |
Why?
| Colonic Neoplasms | 2 | 2022 | 161 | 0.360 |
Why?
| Genetic Loci | 3 | 2015 | 49 | 0.350 |
Why?
| Gene Expression Profiling | 8 | 2023 | 1032 | 0.350 |
Why?
| Cyclophosphamide | 2 | 2021 | 165 | 0.350 |
Why?
| Galactokinase | 3 | 2015 | 10 | 0.350 |
Why?
| Methylation | 5 | 2023 | 122 | 0.350 |
Why?
| CTLA-4 Antigen | 2 | 2021 | 25 | 0.340 |
Why?
| Melanoma, Experimental | 2 | 2021 | 45 | 0.340 |
Why?
| Osteosarcoma | 1 | 2010 | 47 | 0.340 |
Why?
| Virulence Factors | 3 | 2020 | 78 | 0.340 |
Why?
| Histone Code | 2 | 2021 | 32 | 0.340 |
Why?
| Virus Replication | 2 | 2024 | 140 | 0.340 |
Why?
| Trans-Activators | 2 | 2020 | 134 | 0.330 |
Why?
| Protein Kinase Inhibitors | 2 | 2021 | 204 | 0.330 |
Why?
| Doxorubicin | 2 | 2021 | 233 | 0.320 |
Why?
| Multiple Myeloma | 4 | 2023 | 2929 | 0.320 |
Why?
| Nerve Tissue Proteins | 2 | 2021 | 193 | 0.310 |
Why?
| Neoplasms | 4 | 2021 | 1235 | 0.310 |
Why?
| Hippocampus | 2 | 2020 | 228 | 0.310 |
Why?
| Breast Neoplasms | 5 | 2024 | 1174 | 0.310 |
Why?
| Weight Gain | 3 | 2024 | 240 | 0.300 |
Why?
| Cell Proliferation | 7 | 2023 | 1007 | 0.300 |
Why?
| Male | 22 | 2024 | 25241 | 0.290 |
Why?
| Sirtuin 3 | 2 | 2024 | 19 | 0.290 |
Why?
| Female | 23 | 2024 | 26472 | 0.290 |
Why?
| Diet | 2 | 2021 | 566 | 0.280 |
Why?
| Drug Resistance, Neoplasm | 2 | 2020 | 308 | 0.280 |
Why?
| Osteomyelitis | 2 | 2019 | 126 | 0.280 |
Why?
| RNA | 2 | 2024 | 170 | 0.270 |
Why?
| HEK293 Cells | 7 | 2021 | 222 | 0.270 |
Why?
| Fungal Proteins | 2 | 2020 | 118 | 0.270 |
Why?
| Mutation | 7 | 2020 | 1294 | 0.270 |
Why?
| Antiviral Agents | 2 | 2024 | 173 | 0.260 |
Why?
| Lung | 3 | 2024 | 486 | 0.260 |
Why?
| Lung Neoplasms | 2 | 2024 | 606 | 0.260 |
Why?
| Organoids | 2 | 2023 | 39 | 0.260 |
Why?
| Gene Expression Regulation, Bacterial | 4 | 2020 | 191 | 0.250 |
Why?
| Tumor Microenvironment | 3 | 2021 | 212 | 0.250 |
Why?
| RNA-Binding Proteins | 3 | 2021 | 123 | 0.250 |
Why?
| Disease Models, Animal | 5 | 2021 | 1455 | 0.250 |
Why?
| Co-Repressor Proteins | 2 | 2023 | 19 | 0.250 |
Why?
| Lab-On-A-Chip Devices | 1 | 2024 | 5 | 0.240 |
Why?
| Cell Line | 4 | 2023 | 1000 | 0.240 |
Why?
| Proteolysis | 2 | 2022 | 94 | 0.240 |
Why?
| Cell Cycle Proteins | 3 | 2021 | 166 | 0.240 |
Why?
| Oxidative Stress | 4 | 2023 | 770 | 0.240 |
Why?
| Calcinosis | 1 | 2024 | 49 | 0.230 |
Why?
| Th1 Cells | 1 | 2024 | 52 | 0.230 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2022 | 92 | 0.230 |
Why?
| Chiroptera | 1 | 2023 | 5 | 0.230 |
Why?
| Mitochondrial Proteins | 1 | 2024 | 90 | 0.230 |
Why?
| Retroelements | 1 | 2023 | 14 | 0.230 |
Why?
| Databases, Protein | 1 | 2024 | 29 | 0.230 |
Why?
| Cholesterol | 1 | 2024 | 146 | 0.230 |
Why?
| Mediator Complex | 1 | 2023 | 5 | 0.230 |
Why?
| Endogenous Retroviruses | 1 | 2023 | 8 | 0.230 |
Why?
| Interferon Type I | 1 | 2023 | 25 | 0.230 |
Why?
| Protein Kinases | 2 | 2024 | 71 | 0.230 |
Why?
| Viruses | 1 | 2023 | 21 | 0.220 |
Why?
| Cyclin-Dependent Kinases | 1 | 2023 | 28 | 0.220 |
Why?
| Gonadotrophs | 1 | 2023 | 21 | 0.220 |
Why?
| Leishmania | 1 | 2023 | 5 | 0.220 |
Why?
| Aortic Valve Stenosis | 1 | 2024 | 60 | 0.220 |
Why?
| Lymphoma | 1 | 2024 | 66 | 0.220 |
Why?
| Biofilms | 3 | 2020 | 181 | 0.220 |
Why?
| Electrophoresis, Capillary | 1 | 2023 | 11 | 0.220 |
Why?
| Formaldehyde | 2 | 2015 | 52 | 0.220 |
Why?
| Bovine Respiratory Disease Complex | 1 | 2023 | 1 | 0.220 |
Why?
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 78 | 0.220 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2024 | 57 | 0.220 |
Why?
| Leishmaniasis, Cutaneous | 1 | 2023 | 14 | 0.220 |
Why?
| Cattle Diseases | 1 | 2023 | 11 | 0.220 |
Why?
| Aortic Valve | 1 | 2024 | 113 | 0.220 |
Why?
| Amines | 1 | 2023 | 40 | 0.220 |
Why?
| Neuroendocrine Tumors | 1 | 2023 | 23 | 0.220 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2023 | 24 | 0.210 |
Why?
| Staphylococcal Infections | 3 | 2020 | 268 | 0.210 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 105 | 0.210 |
Why?
| Respiratory Tract Diseases | 1 | 2023 | 24 | 0.210 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 9 | 0.210 |
Why?
| Cecum | 2 | 2021 | 63 | 0.210 |
Why?
| Gastrointestinal Neoplasms | 1 | 2023 | 44 | 0.210 |
Why?
| Immunotherapy | 2 | 2021 | 238 | 0.210 |
Why?
| Malnutrition | 1 | 2024 | 87 | 0.210 |
Why?
| Milk, Human | 2 | 2021 | 109 | 0.210 |
Why?
| Peripheral Nerve Injuries | 1 | 2022 | 24 | 0.210 |
Why?
| Leishmania major | 1 | 2022 | 9 | 0.210 |
Why?
| Ikaros Transcription Factor | 1 | 2022 | 6 | 0.210 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2022 | 3 | 0.210 |
Why?
| Weightlessness | 2 | 2020 | 14 | 0.210 |
Why?
| Aging | 2 | 2024 | 687 | 0.210 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 154 | 0.200 |
Why?
| Promoter Regions, Genetic | 3 | 2019 | 475 | 0.200 |
Why?
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2023 | 103 | 0.200 |
Why?
| Liver Failure, Acute | 1 | 2022 | 54 | 0.200 |
Why?
| Gene Expression Regulation | 3 | 2024 | 976 | 0.200 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2024 | 186 | 0.200 |
Why?
| Nuclear Pore Complex Proteins | 1 | 2021 | 8 | 0.200 |
Why?
| End Stage Liver Disease | 1 | 2022 | 44 | 0.200 |
Why?
| Phosphofructokinase-1, Type C | 1 | 2021 | 4 | 0.200 |
Why?
| YY1 Transcription Factor | 1 | 2021 | 7 | 0.200 |
Why?
| Disease Progression | 5 | 2024 | 825 | 0.200 |
Why?
| Spectrum Analysis, Raman | 1 | 2021 | 58 | 0.190 |
Why?
| Tandem Mass Spectrometry | 2 | 2023 | 236 | 0.190 |
Why?
| Molecular Chaperones | 2 | 2020 | 64 | 0.190 |
Why?
| Animals, Newborn | 4 | 2024 | 367 | 0.190 |
Why?
| Activating Transcription Factor 4 | 1 | 2021 | 5 | 0.190 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2022 | 114 | 0.190 |
Why?
| Cadherins | 2 | 2019 | 68 | 0.190 |
Why?
| Uterine Artery | 1 | 2021 | 3 | 0.190 |
Why?
| Cytokines | 1 | 2024 | 612 | 0.190 |
Why?
| Transcription Factor Pit-1 | 1 | 2021 | 16 | 0.190 |
Why?
| Radiation, Ionizing | 1 | 2022 | 100 | 0.190 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2021 | 20 | 0.190 |
Why?
| Cysteine | 1 | 2021 | 50 | 0.190 |
Why?
| Ozone | 1 | 2021 | 19 | 0.190 |
Why?
| Pituitary Gland, Anterior | 1 | 2021 | 37 | 0.190 |
Why?
| Carcinoma, Hepatocellular | 1 | 2023 | 191 | 0.190 |
Why?
| T-Lymphocytes | 2 | 2020 | 338 | 0.190 |
Why?
| Epigenomics | 1 | 2021 | 67 | 0.190 |
Why?
| Homeodomain Proteins | 1 | 2021 | 80 | 0.190 |
Why?
| Septins | 1 | 2020 | 19 | 0.190 |
Why?
| NF-E2-Related Factor 2 | 1 | 2021 | 41 | 0.190 |
Why?
| Cryptococcus neoformans | 1 | 2020 | 27 | 0.190 |
Why?
| Acetylation | 4 | 2024 | 97 | 0.180 |
Why?
| Milk Substitutes | 1 | 2020 | 6 | 0.180 |
Why?
| Cranial Irradiation | 1 | 2020 | 21 | 0.180 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 83 | 0.180 |
Why?
| Blood-Brain Barrier | 1 | 2020 | 48 | 0.180 |
Why?
| Chlamydia trachomatis | 1 | 2020 | 30 | 0.180 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 130 | 0.180 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 55 | 0.180 |
Why?
| Cervix Uteri | 1 | 2020 | 49 | 0.180 |
Why?
| Up-Regulation | 3 | 2018 | 452 | 0.180 |
Why?
| Amino Acid Motifs | 1 | 2020 | 56 | 0.180 |
Why?
| Metalloporphyrins | 1 | 2020 | 7 | 0.180 |
Why?
| Workflow | 1 | 2020 | 51 | 0.180 |
Why?
| Social Behavior | 1 | 2020 | 72 | 0.180 |
Why?
| Insulin Resistance | 1 | 2022 | 264 | 0.180 |
Why?
| Neoplasms, Experimental | 1 | 2020 | 114 | 0.180 |
Why?
| Infant Formula | 1 | 2021 | 145 | 0.170 |
Why?
| Memory | 1 | 2020 | 116 | 0.170 |
Why?
| Neovascularization, Pathologic | 1 | 2021 | 161 | 0.170 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 169 | 0.170 |
Why?
| Paclitaxel | 1 | 2020 | 84 | 0.170 |
Why?
| Databases, Genetic | 1 | 2020 | 88 | 0.170 |
Why?
| Osteogenesis Imperfecta | 1 | 2020 | 38 | 0.170 |
Why?
| Extracellular Matrix Proteins | 1 | 2020 | 69 | 0.170 |
Why?
| DNA Breaks, Double-Stranded | 2 | 2017 | 72 | 0.170 |
Why?
| Liver Neoplasms | 1 | 2023 | 326 | 0.170 |
Why?
| Adaptation, Ocular | 1 | 2019 | 3 | 0.170 |
Why?
| Translocation, Genetic | 1 | 2021 | 264 | 0.170 |
Why?
| Immunologic Memory | 1 | 2019 | 30 | 0.170 |
Why?
| Chlamydia Infections | 1 | 2020 | 77 | 0.170 |
Why?
| Blood-Retinal Barrier | 1 | 2019 | 6 | 0.170 |
Why?
| Poly(A)-Binding Proteins | 1 | 2019 | 6 | 0.170 |
Why?
| Neoplasm Proteins | 2 | 2012 | 322 | 0.170 |
Why?
| Ribonucleoproteins | 1 | 2019 | 17 | 0.170 |
Why?
| Collagen Type I | 1 | 2020 | 89 | 0.170 |
Why?
| Behavior, Animal | 1 | 2020 | 181 | 0.170 |
Why?
| Xenopus Proteins | 1 | 2019 | 27 | 0.170 |
Why?
| CpG Islands | 1 | 2019 | 108 | 0.170 |
Why?
| Ruminococcus | 1 | 2019 | 8 | 0.170 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2021 | 185 | 0.170 |
Why?
| Integrin alpha Chains | 1 | 2019 | 11 | 0.170 |
Why?
| Arsenic | 1 | 2019 | 24 | 0.160 |
Why?
| Colorectal Neoplasms | 1 | 2022 | 236 | 0.160 |
Why?
| Oxidation-Reduction | 1 | 2020 | 322 | 0.160 |
Why?
| Cell Cycle Checkpoints | 1 | 2019 | 32 | 0.160 |
Why?
| Gravity, Altered | 1 | 2018 | 3 | 0.160 |
Why?
| Starch | 1 | 2019 | 28 | 0.160 |
Why?
| Quality Indicators, Health Care | 1 | 2019 | 86 | 0.160 |
Why?
| Profilins | 1 | 2018 | 16 | 0.160 |
Why?
| Chromans | 1 | 2018 | 37 | 0.160 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 40 | 0.160 |
Why?
| Obesity | 2 | 2023 | 1113 | 0.160 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 989 | 0.150 |
Why?
| Accidental Falls | 1 | 2019 | 98 | 0.150 |
Why?
| Retina | 1 | 2018 | 64 | 0.150 |
Why?
| Mice, Knockout | 4 | 2024 | 841 | 0.150 |
Why?
| Models, Biological | 2 | 2012 | 727 | 0.150 |
Why?
| Vitamin E | 1 | 2018 | 81 | 0.150 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 76 | 0.150 |
Why?
| Nuclear Proteins | 2 | 2017 | 242 | 0.150 |
Why?
| Cells, Cultured | 3 | 2021 | 1573 | 0.150 |
Why?
| Antigens, CD | 1 | 2019 | 219 | 0.150 |
Why?
| Neurodegenerative Diseases | 1 | 2018 | 76 | 0.150 |
Why?
| Spleen | 1 | 2018 | 172 | 0.150 |
Why?
| Algorithms | 1 | 2021 | 615 | 0.150 |
Why?
| Apoptosis | 5 | 2021 | 1101 | 0.150 |
Why?
| Cell Differentiation | 5 | 2021 | 651 | 0.140 |
Why?
| Cognition | 1 | 2020 | 338 | 0.140 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 102 | 0.140 |
Why?
| Radiation Injuries | 1 | 2018 | 113 | 0.140 |
Why?
| Muscle Development | 2 | 2014 | 24 | 0.140 |
Why?
| Macaca mulatta | 1 | 2017 | 93 | 0.140 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2017 | 38 | 0.140 |
Why?
| Gamma Rays | 1 | 2017 | 49 | 0.140 |
Why?
| Brain Neoplasms | 1 | 2020 | 287 | 0.140 |
Why?
| Neurogenesis | 3 | 2022 | 27 | 0.140 |
Why?
| Swine | 3 | 2024 | 393 | 0.140 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2017 | 184 | 0.140 |
Why?
| Myogenin | 2 | 2014 | 6 | 0.140 |
Why?
| Butadienes | 1 | 2017 | 48 | 0.140 |
Why?
| Mitochondria, Liver | 1 | 2017 | 70 | 0.140 |
Why?
| Nucleosomes | 2 | 2013 | 13 | 0.140 |
Why?
| Mice, Inbred BALB C | 3 | 2021 | 304 | 0.140 |
Why?
| Antineoplastic Agents | 2 | 2022 | 1171 | 0.140 |
Why?
| Cytochrome P-450 CYP2E1 | 1 | 2017 | 113 | 0.140 |
Why?
| Adenine | 1 | 2016 | 32 | 0.140 |
Why?
| Brain | 2 | 2023 | 1328 | 0.130 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 169 | 0.130 |
Why?
| Tumor Burden | 1 | 2016 | 132 | 0.130 |
Why?
| Chromatography, Liquid | 2 | 2020 | 232 | 0.130 |
Why?
| Rhadinovirus | 1 | 2015 | 17 | 0.130 |
Why?
| Antigens, Viral | 1 | 2015 | 44 | 0.130 |
Why?
| Carcinogens | 1 | 2017 | 199 | 0.130 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 181 | 0.130 |
Why?
| Homologous Recombination | 1 | 2015 | 40 | 0.120 |
Why?
| Cell Cycle | 3 | 2024 | 231 | 0.120 |
Why?
| Histone Acetyltransferases | 1 | 2014 | 22 | 0.120 |
Why?
| Cell Culture Techniques | 1 | 2015 | 99 | 0.120 |
Why?
| Host-Pathogen Interactions | 1 | 2015 | 134 | 0.120 |
Why?
| T-Box Domain Proteins | 1 | 2014 | 14 | 0.120 |
Why?
| Rhabdomyosarcoma | 1 | 2014 | 13 | 0.120 |
Why?
| Threonine | 1 | 2013 | 16 | 0.120 |
Why?
| Megakaryocytes | 1 | 2013 | 21 | 0.110 |
Why?
| Time Factors | 2 | 2017 | 2903 | 0.110 |
Why?
| Mitosis | 1 | 2013 | 91 | 0.110 |
Why?
| Protein Biosynthesis | 3 | 2023 | 253 | 0.110 |
Why?
| Tumor Cells, Cultured | 3 | 2021 | 465 | 0.110 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 459 | 0.110 |
Why?
| Sarcoma | 1 | 2014 | 67 | 0.110 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2013 | 23 | 0.110 |
Why?
| Eukaryotic Initiation Factor-2 | 2 | 2023 | 18 | 0.110 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2012 | 10 | 0.110 |
Why?
| Chromosomes, Fungal | 1 | 2012 | 12 | 0.110 |
Why?
| Serotonin | 1 | 2013 | 152 | 0.100 |
Why?
| DNA Repair Enzymes | 1 | 2012 | 44 | 0.100 |
Why?
| Immunohistochemistry | 2 | 2013 | 973 | 0.100 |
Why?
| Neoadjuvant Therapy | 2 | 2024 | 114 | 0.100 |
Why?
| Homocysteine | 2 | 2024 | 128 | 0.100 |
Why?
| gp100 Melanoma Antigen | 1 | 2011 | 9 | 0.100 |
Why?
| Fixatives | 1 | 2011 | 13 | 0.100 |
Why?
| Phosphorylation | 3 | 2023 | 535 | 0.100 |
Why?
| Tissue Fixation | 1 | 2011 | 36 | 0.100 |
Why?
| High-Throughput Screening Assays | 1 | 2011 | 37 | 0.100 |
Why?
| Paraffin Embedding | 1 | 2011 | 53 | 0.100 |
Why?
| Oncogene Proteins, Fusion | 2 | 2021 | 58 | 0.090 |
Why?
| Transcriptional Activation | 2 | 2021 | 121 | 0.090 |
Why?
| Heat-Shock Response | 2 | 2020 | 28 | 0.090 |
Why?
| Models, Animal | 2 | 2021 | 233 | 0.090 |
Why?
| DNA | 2 | 2024 | 541 | 0.090 |
Why?
| Chromosome Positioning | 1 | 2009 | 2 | 0.090 |
Why?
| DNA Copy Number Variations | 2 | 2022 | 110 | 0.080 |
Why?
| DNA Repair | 3 | 2017 | 193 | 0.080 |
Why?
| Prostatic Neoplasms | 2 | 2010 | 394 | 0.080 |
Why?
| Mice, SCID | 2 | 2021 | 175 | 0.080 |
Why?
| Radiation-Protective Agents | 2 | 2020 | 74 | 0.080 |
Why?
| Enhancer Elements, Genetic | 2 | 2021 | 61 | 0.080 |
Why?
| Mice, Transgenic | 2 | 2021 | 555 | 0.080 |
Why?
| RNA, Messenger | 2 | 2023 | 1105 | 0.080 |
Why?
| Chromatin Assembly and Disassembly | 2 | 2021 | 25 | 0.080 |
Why?
| Rats, Sprague-Dawley | 2 | 2021 | 1597 | 0.070 |
Why?
| Phenotype | 2 | 2020 | 729 | 0.070 |
Why?
| Osteoblasts | 2 | 2020 | 450 | 0.070 |
Why?
| Pregnancy | 2 | 2024 | 2607 | 0.060 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2019 | 53 | 0.060 |
Why?
| Hydrogels | 1 | 2024 | 15 | 0.060 |
Why?
| Mice, Inbred MRL lpr | 1 | 2024 | 36 | 0.060 |
Why?
| Autoimmunity | 1 | 2024 | 35 | 0.060 |
Why?
| Coculture Techniques | 1 | 2024 | 146 | 0.060 |
Why?
| Jamaica | 1 | 2023 | 9 | 0.060 |
Why?
| Terminal Repeat Sequences | 1 | 2023 | 11 | 0.060 |
Why?
| S-Adenosylmethionine | 1 | 2024 | 63 | 0.060 |
Why?
| Axilla | 1 | 2024 | 89 | 0.060 |
Why?
| Transfection | 2 | 2016 | 354 | 0.060 |
Why?
| Caloric Restriction | 1 | 2024 | 36 | 0.060 |
Why?
| Extracellular Matrix | 1 | 2024 | 111 | 0.060 |
Why?
| MyoD Protein | 2 | 2014 | 10 | 0.060 |
Why?
| Lactation | 1 | 2024 | 62 | 0.060 |
Why?
| Follicle Stimulating Hormone | 1 | 2023 | 43 | 0.060 |
Why?
| Hepatitis B virus | 1 | 2023 | 27 | 0.060 |
Why?
| Interferon-gamma | 1 | 2024 | 177 | 0.060 |
Why?
| Microvessels | 1 | 2023 | 29 | 0.060 |
Why?
| Genome | 1 | 2023 | 65 | 0.060 |
Why?
| Immunity, Innate | 1 | 2024 | 104 | 0.060 |
Why?
| Rats | 2 | 2021 | 3305 | 0.060 |
Why?
| Histone Deacetylases | 1 | 2023 | 50 | 0.060 |
Why?
| Integrin beta Chains | 1 | 2023 | 14 | 0.050 |
Why?
| Homeostasis | 1 | 2024 | 200 | 0.050 |
Why?
| Autoimmune Diseases | 1 | 2024 | 101 | 0.050 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2024 | 116 | 0.050 |
Why?
| Integrins | 1 | 2023 | 31 | 0.050 |
Why?
| Sural Nerve | 1 | 2022 | 8 | 0.050 |
Why?
| Lymphatic Metastasis | 1 | 2024 | 224 | 0.050 |
Why?
| Lymph Node Excision | 1 | 2024 | 134 | 0.050 |
Why?
| Nerve Regeneration | 1 | 2022 | 21 | 0.050 |
Why?
| Cytogenetic Analysis | 1 | 2023 | 82 | 0.050 |
Why?
| Osteoporosis | 1 | 2024 | 146 | 0.050 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2023 | 86 | 0.050 |
Why?
| Amino Acid Sequence | 2 | 2014 | 585 | 0.050 |
Why?
| Dogs | 1 | 2023 | 182 | 0.050 |
Why?
| Molecular Sequence Data | 2 | 2014 | 792 | 0.050 |
Why?
| Peripheral Nerves | 1 | 2022 | 49 | 0.050 |
Why?
| Cattle | 1 | 2023 | 210 | 0.050 |
Why?
| L-Lactate Dehydrogenase | 1 | 2022 | 65 | 0.050 |
Why?
| Hepatocytes | 1 | 2023 | 182 | 0.050 |
Why?
| Cell Respiration | 1 | 2022 | 41 | 0.050 |
Why?
| Lymph Nodes | 1 | 2024 | 260 | 0.050 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 116 | 0.050 |
Why?
| Carrier Proteins | 1 | 2023 | 304 | 0.050 |
Why?
| Colonoscopy | 1 | 2022 | 93 | 0.050 |
Why?
| Protein Structure, Tertiary | 2 | 2014 | 253 | 0.050 |
Why?
| Glycoproteins | 1 | 2022 | 115 | 0.050 |
Why?
| NF-kappa B | 1 | 2023 | 314 | 0.050 |
Why?
| Neoplasm Staging | 1 | 2024 | 740 | 0.050 |
Why?
| Mutagenesis, Site-Directed | 1 | 2021 | 99 | 0.050 |
Why?
| Mice, 129 Strain | 1 | 2021 | 38 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 197 | 0.050 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2021 | 33 | 0.050 |
Why?
| NIH 3T3 Cells | 1 | 2021 | 52 | 0.050 |
Why?
| Registries | 1 | 2024 | 522 | 0.050 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2021 | 47 | 0.050 |
Why?
| Cryptococcosis | 1 | 2020 | 20 | 0.050 |
Why?
| Glycolysis | 1 | 2021 | 70 | 0.050 |
Why?
| Asymptomatic Infections | 1 | 2020 | 6 | 0.050 |
Why?
| Cell Lineage | 1 | 2021 | 83 | 0.050 |
Why?
| Lipid Peroxidation | 1 | 2021 | 100 | 0.050 |
Why?
| Protein Stability | 1 | 2020 | 43 | 0.050 |
Why?
| Chemotherapy, Adjuvant | 1 | 2021 | 119 | 0.050 |
Why?
| GTP Phosphohydrolases | 1 | 2020 | 31 | 0.050 |
Why?
| rac1 GTP-Binding Protein | 1 | 2020 | 11 | 0.050 |
Why?
| Somatotrophs | 1 | 2021 | 37 | 0.050 |
Why?
| Immunity, Cellular | 1 | 2020 | 69 | 0.050 |
Why?
| Dendritic Spines | 1 | 2020 | 21 | 0.050 |
Why?
| HeLa Cells | 1 | 2021 | 250 | 0.050 |
Why?
| Sirtuins | 1 | 2020 | 11 | 0.050 |
Why?
| Genome, Human | 1 | 2021 | 111 | 0.050 |
Why?
| Bacterial Toxins | 1 | 2020 | 52 | 0.050 |
Why?
| Metalloendopeptidases | 1 | 2020 | 70 | 0.050 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2021 | 138 | 0.050 |
Why?
| Macrophages | 1 | 2023 | 363 | 0.050 |
Why?
| Early Detection of Cancer | 1 | 2022 | 169 | 0.050 |
Why?
| Dentate Gyrus | 1 | 2020 | 17 | 0.040 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2020 | 211 | 0.040 |
Why?
| Biological Transport | 1 | 2020 | 174 | 0.040 |
Why?
| CA1 Region, Hippocampal | 1 | 2020 | 24 | 0.040 |
Why?
| Drug Discovery | 1 | 2020 | 85 | 0.040 |
Why?
| Skin | 1 | 2023 | 409 | 0.040 |
Why?
| Radiotherapy | 1 | 2021 | 128 | 0.040 |
Why?
| Cell Transformation, Neoplastic | 1 | 2021 | 177 | 0.040 |
Why?
| Neoplastic Stem Cells | 1 | 2021 | 103 | 0.040 |
Why?
| Bacteria | 1 | 2021 | 224 | 0.040 |
Why?
| Insulin | 1 | 2022 | 457 | 0.040 |
Why?
| Stem Cells | 1 | 2021 | 171 | 0.040 |
Why?
| Oncology Service, Hospital | 1 | 2019 | 15 | 0.040 |
Why?
| Poly(A)-Binding Protein I | 1 | 2019 | 6 | 0.040 |
Why?
| Zonula Occludens-1 Protein | 1 | 2019 | 8 | 0.040 |
Why?
| Oogenesis | 1 | 2019 | 16 | 0.040 |
Why?
| Aquaporin 4 | 1 | 2019 | 9 | 0.040 |
Why?
| Polyadenylation | 1 | 2019 | 20 | 0.040 |
Why?
| Crystallins | 1 | 2019 | 12 | 0.040 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2019 | 30 | 0.040 |
Why?
| Placenta | 1 | 2021 | 132 | 0.040 |
Why?
| Xenopus laevis | 1 | 2019 | 38 | 0.040 |
Why?
| Eye Proteins | 1 | 2019 | 17 | 0.040 |
Why?
| Arsenate Reductases | 1 | 2019 | 5 | 0.040 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 12 | 0.040 |
Why?
| Hematopoietic Stem Cells | 1 | 2021 | 184 | 0.040 |
Why?
| Acetaminophen | 1 | 2022 | 283 | 0.040 |
Why?
| Intraocular Pressure | 1 | 2019 | 53 | 0.040 |
Why?
| Membrane Transport Proteins | 1 | 2019 | 49 | 0.040 |
Why?
| Oocytes | 1 | 2019 | 74 | 0.040 |
Why?
| Geriatrics | 1 | 2019 | 46 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2022 | 945 | 0.040 |
Why?
| Mass Screening | 1 | 2022 | 353 | 0.040 |
Why?
| Motor Neurons | 1 | 2018 | 39 | 0.040 |
Why?
| Retinal Pigment Epithelium | 1 | 2018 | 18 | 0.040 |
Why?
| Actin Cytoskeleton | 1 | 2018 | 22 | 0.040 |
Why?
| Neuroglia | 1 | 2018 | 43 | 0.040 |
Why?
| Membrane Proteins | 1 | 2020 | 341 | 0.040 |
Why?
| Pilot Projects | 1 | 2020 | 699 | 0.040 |
Why?
| Protein Phosphatase 2 | 1 | 2017 | 5 | 0.040 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 116 | 0.040 |
Why?
| Antioxidants | 1 | 2020 | 249 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2018 | 91 | 0.040 |
Why?
| Prospective Studies | 1 | 2024 | 2364 | 0.040 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 181 | 0.040 |
Why?
| Repressor Proteins | 1 | 2019 | 151 | 0.040 |
Why?
| Wnt Signaling Pathway | 1 | 2018 | 92 | 0.040 |
Why?
| Spinal Cord | 1 | 2018 | 177 | 0.040 |
Why?
| Quality Improvement | 1 | 2019 | 208 | 0.040 |
Why?
| Electron Transport Complex III | 1 | 2017 | 7 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 1 | 2020 | 1376 | 0.040 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 23 | 0.040 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 25 | 0.040 |
Why?
| Electron Transport Complex I | 1 | 2017 | 23 | 0.040 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2017 | 47 | 0.040 |
Why?
| Prognosis | 1 | 2022 | 1942 | 0.040 |
Why?
| Operon | 1 | 2016 | 29 | 0.030 |
Why?
| Middle Aged | 3 | 2020 | 12069 | 0.030 |
Why?
| Thiolester Hydrolases | 1 | 2016 | 7 | 0.030 |
Why?
| Reactive Oxygen Species | 1 | 2018 | 408 | 0.030 |
Why?
| X Chromosome | 1 | 2016 | 13 | 0.030 |
Why?
| Ubiquitin Thiolesterase | 1 | 2016 | 18 | 0.030 |
Why?
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 16 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2016 | 68 | 0.030 |
Why?
| Mammals | 1 | 2016 | 56 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2016 | 96 | 0.030 |
Why?
| Ubiquitination | 1 | 2016 | 43 | 0.030 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2016 | 38 | 0.030 |
Why?
| Centrifugation | 1 | 2015 | 14 | 0.030 |
Why?
| Endopeptidases | 1 | 2016 | 66 | 0.030 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 44 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2016 | 107 | 0.030 |
Why?
| Protein Interaction Maps | 1 | 2015 | 23 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2015 | 59 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 112 | 0.030 |
Why?
| RNA Interference | 1 | 2016 | 179 | 0.030 |
Why?
| Isotope Labeling | 1 | 2015 | 53 | 0.030 |
Why?
| Evolution, Molecular | 1 | 2016 | 99 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2020 | 1557 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 2015 | 231 | 0.030 |
Why?
| Genotype | 1 | 2016 | 537 | 0.030 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2014 | 7 | 0.030 |
Why?
| Gene Deletion | 1 | 2015 | 266 | 0.030 |
Why?
| Open Reading Frames | 1 | 2014 | 55 | 0.030 |
Why?
| Sequence Alignment | 1 | 2014 | 121 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 85 | 0.030 |
Why?
| Plasmids | 1 | 2014 | 161 | 0.030 |
Why?
| Antibody Specificity | 1 | 2013 | 36 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 252 | 0.030 |
Why?
| Antibodies | 1 | 2013 | 154 | 0.030 |
Why?
| Escherichia coli | 1 | 2014 | 186 | 0.030 |
Why?
| Aged | 2 | 2019 | 9310 | 0.030 |
Why?
| Acid Anhydride Hydrolases | 1 | 2012 | 15 | 0.030 |
Why?
| Muscles | 1 | 2013 | 103 | 0.030 |
Why?
| Models, Molecular | 1 | 2013 | 338 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 411 | 0.030 |
Why?
| Peptide Fragments | 1 | 2013 | 215 | 0.030 |
Why?
| DNA, Neoplasm | 1 | 2012 | 147 | 0.030 |
Why?
| Aged, 80 and over | 1 | 2019 | 3129 | 0.020 |
Why?
| Young Adult | 1 | 2020 | 3958 | 0.020 |
Why?
| Retrospective Studies | 1 | 2023 | 6108 | 0.020 |
Why?
| Treatment Outcome | 1 | 2020 | 5141 | 0.020 |
Why?
| Child | 1 | 2022 | 6847 | 0.020 |
Why?
| Transcriptional Elongation Factors | 1 | 2009 | 18 | 0.020 |
Why?
| Epistasis, Genetic | 1 | 2009 | 29 | 0.020 |
Why?
| Adolescent | 1 | 2020 | 6356 | 0.020 |
Why?
| Cohort Studies | 1 | 2013 | 1422 | 0.020 |
Why?
| Recombinant Fusion Proteins | 1 | 2009 | 181 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2009 | 369 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2013 | 750 | 0.020 |
Why?
| Forecasting | 1 | 2007 | 150 | 0.020 |
Why?
| Adult | 1 | 2020 | 13236 | 0.020 |
Why?
|
|
Byrum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|